OMNIAB, INC. Lease, Cost
OMNIAB, INC. (OABI) reported Lease, Cost of $1.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-06
- OMNIAB, INC. lease, cost for the quarter ending 2026-06-30 was $1.17M, a 4.72% decline year-over-year.
- OMNIAB, INC. lease, cost for the quarter ending 2026-03-31 was $1.11M, a 5.91% increase year-over-year.
- OMNIAB, INC. lease, cost for the quarter ending 2025-12-31 was $1.23M, a 2.62% decline year-over-year.
- OMNIAB, INC. lease, cost for the quarter ending 2025-09-30 was $1.23M, a 6.98% decline year-over-year.
- OMNIAB, INC. lease, cost for fiscal 2025 was $4.73M, a 5.21% decline from fiscal 2024.
- OMNIAB, INC. lease, cost for fiscal 2024 was $4.99M, a 6.19% increase from fiscal 2023.
- OMNIAB, INC. lease, cost for fiscal 2023 was $4.70M, a 8.72% increase from fiscal 2022.
- OMNIAB, INC. lease, cost for fiscal 2022 was $4.32M, a 94.07% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.17M 10-Q · filed 2026-08-06 | $2.28M 10-Q · filed 2026-08-06 | $3.51M derived: sum of 3 quarters · filed 2026-08-06 | $4.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.11M 10-Q · filed 2026-05-07 | $2.34M derived: sum of 2 quarters · filed 2026-05-07 | $3.56M derived: sum of 3 quarters · filed 2026-05-07 | $4.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.45M derived: sum of 2 quarters · filed 2026-03-04 | $3.68M derived: sum of 3 quarters · filed 2026-08-06 | $4.73M 10-K · filed 2026-03-04 |
| 2025-09-30 | $1.23M 10-Q · filed 2025-11-04 | $2.45M derived: sum of 2 quarters · filed 2026-08-06 | $3.50M 10-Q · filed 2025-11-04 | $4.76M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.23M 10-Q · filed 2026-08-06 | $2.28M 10-Q · filed 2026-08-06 | $3.54M derived: sum of 3 quarters · filed 2026-08-06 | $4.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.05M 10-Q · filed 2026-05-07 | $2.31M derived: sum of 2 quarters · filed 2026-05-07 | $3.63M derived: sum of 3 quarters · filed 2026-05-07 | $4.86M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.58M derived: sum of 2 quarters · filed 2026-03-04 | $3.81M derived: sum of 3 quarters · filed 2026-03-04 | $4.99M 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.32M 10-Q · filed 2025-11-04 | $2.55M derived: sum of 2 quarters · filed 2025-11-04 | $3.73M 10-Q · filed 2025-11-04 | $4.98M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $1.24M 10-Q · filed 2025-08-06 | $2.41M 10-Q · filed 2025-08-06 | $3.66M derived: sum of 3 quarters · filed 2025-08-06 | $4.83M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $1.18M 10-Q · filed 2025-05-08 | $2.43M derived: sum of 2 quarters · filed 2025-05-08 | $3.59M derived: sum of 3 quarters · filed 2025-05-08 | $4.73M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $2.42M derived: sum of 2 quarters · filed 2025-03-18 | $3.56M derived: sum of 3 quarters · filed 2025-03-18 | $4.70M 10-K · filed 2025-03-18 |
| 2023-09-30 | $1.17M 10-Q · filed 2024-11-12 | $2.31M derived: sum of 2 quarters · filed 2024-11-12 | $3.45M 10-Q · filed 2024-11-12 | $3.71M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.14M 10-Q · filed 2024-08-08 | $2.26M 10-Q · filed 2024-08-08 | $2.54M derived: sum of 3 quarters · filed 2024-08-08 | $3.99M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.12M 10-Q · filed 2024-05-09 | $1.40M derived: sum of 2 quarters · filed 2024-05-09 | $2.85M derived: sum of 3 quarters · filed 2024-05-09 | $4.39M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $1.74M derived: sum of 2 quarters · filed 2024-03-25 | $3.28M derived: sum of 3 quarters · filed 2024-03-25 | $4.32M 10-K · filed 2024-03-25 |
| 2022-09-30 | $1.45M 10-Q · filed 2023-11-09 | $2.99M derived: sum of 2 quarters · filed 2023-11-09 | $4.04M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.54M 10-Q · filed 2023-08-10 | $2.59M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $1.04M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $2.23M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |